ConditionBones, joints & muscles
Mitochondrial Myopathy
Mitochondrial myopathy is a muscle disease caused by faulty mitochondria, the parts of cells that turn food and oxygen into energy. Muscles use a lot of energy, so they are often the first tissue affected. Typical signs are muscle weakness, fatigue and pain with exercise, and drooping eyelids with limited eye movement. It is genetic, varies hugely in severity and often affects other organs. There is no cure, but exercise, supplements and careful monitoring help many people stay active.
Also called: Mitochondrial muscle disease, mitochondrial encephalomyopathy (when the brain is involved)
At a glance
- What it is
- A genetic muscle disease caused by mitochondria that cannot produce enough energy.
- Main symptoms
- Weakness, early fatigue and muscle pain on exertion, drooping eyelids and limited eye movement.
- Often affects
- Heart, brain, hearing, eyes, gut and hormones too, as part of wider mitochondrial disease.
- Diagnosis
- Blood lactate and CK tests, genetic testing, and sometimes a muscle biopsy.
- Treatment
- Tailored exercise, supplements, monitoring for heart and other problems, and avoiding certain medicines.
When to get help
Call 911 or go to the ER
- Sudden severe weakness, breathing difficulty or trouble swallowing
- Stroke-like symptoms: sudden weakness on one side, vision loss, confusion or a seizure
- Fainting, a very slow pulse or palpitations (possible heart block)
- Dark brown urine with severe muscle pain after exercise or illness (possible rhabdomyolysis)
See a doctor within a day or two
- Vomiting, fast breathing and drowsiness during an illness (possible lactic acidosis)
- Any infection or fasting illness that stops you eating, if you have mitochondrial disease
Book a routine appointment
- Muscles that tire much faster than expected for your fitness, with pain or cramps
- Drooping eyelids, especially both sides, or difficulty moving the eyes
- Unexplained weakness with hearing loss, diabetes or heart problems in the family
What happens in mitochondrial myopathy
Mitochondria contain the respiratory chain, a series of enzyme complexes that use oxygen to make ATP, the cell's energy molecule. Mitochondria have their own small set of DNA (mtDNA), inherited only from the mother, but most mitochondrial proteins are coded by genes in the cell nucleus.
A change in either set of genes can disable the respiratory chain. Muscle cells then switch to less efficient energy production, which makes lactic acid and leaves the muscle short of energy, especially during exercise. Because each cell contains many mitochondria, a person can carry a mix of normal and faulty mtDNA (heteroplasmy). The proportion affects how severe the disease is and which organs are involved, which is why members of the same family can be affected very differently.
Symptoms
Muscle symptoms
- Exercise intolerance: tiring far sooner than expected, with heaviness, aching or burning in the muscles
- Weakness, usually of muscles close to the trunk (shoulders and hips) and the neck
- Muscle pain and cramps after exertion
- Drooping eyelids (ptosis) and limited eye movement (ophthalmoplegia), often slowly progressing over years; double vision is less common than expected
- Weakness of facial and swallowing muscles
- Rarely, muscle breakdown (rhabdomyolysis) after exercise, fasting or infection
Symptoms in other organs
- Heart: cardiomyopathy and heart rhythm problems, including heart block
- Brain: stroke-like episodes, seizures, migraines, learning difficulties, balance problems
- Ears and eyes: hearing loss, retinal changes, optic nerve damage
- Hormones: diabetes, short stature
- Gut: swallowing problems, constipation, poor weight gain
- Nerves: numbness in the feet
Common syndromes
| Syndrome | Key features |
|---|---|
| CPEO (chronic progressive external ophthalmoplegia) | Slowly worsening ptosis and eye movement limitation, often with limb weakness; adult onset |
| Kearns-Sayre syndrome | CPEO before age 20, retinal pigment changes, heart block |
| MELAS | Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes; also diabetes, hearing loss |
| MERRF | Myoclonic epilepsy with ragged-red fibers, weakness, ataxia |
| Isolated mitochondrial myopathy | Exercise intolerance and weakness without other organs affected |
| TK2 deficiency | Weakness of limbs, face and breathing muscles, often in childhood |
For the wider group of disorders, see mitochondrial disease.
How it is diagnosed
- History and family tree, including relatives on the mother's side with hearing loss, diabetes, heart disease or neurological problems.
- Blood tests: lactate and pyruvate (often raised, especially after exercise), creatine kinase (CK, normal or mildly raised), and blood sugar.
- Genetic testing: often the first-line test now, using blood, urine or saliva for mtDNA and panels or whole-exome or genome sequencing for nuclear genes. Some mtDNA changes are found only in muscle.
- Muscle biopsy: shows "ragged-red fibers" and fibers lacking the enzyme cytochrome c oxidase, and allows mtDNA and enzyme testing.
- Other tests: electromyography (EMG), heart ECG and echocardiogram, hearing and eye exams, brain MRI if neurological symptoms are present, and exercise testing.
Other causes of weakness and ptosis, such as myasthenia gravis and muscular dystrophy, are excluded.
Treatment
There is no cure yet. Care aims to maximize energy, prevent complications and treat organ involvement.
- Exercise: supervised aerobic and resistance training, started gently and increased slowly, improves strength and endurance and is safe for most people. Avoid sudden extreme exertion.
- Supplements: coenzyme Q10, L-carnitine, riboflavin and other vitamins are often used. Evidence is limited, so discuss them with your specialist. Specific deficiencies, such as CoQ10 deficiency, respond well. L-arginine or citrulline may be used in MELAS stroke-like episodes.
- Eyelid surgery: a brow suspension or eyelid lift can improve ptosis that blocks vision.
- Heart monitoring: a yearly ECG and regular echocardiograms; a pacemaker if heart block develops.
- Nutrition: regular meals, avoiding long fasts, and extra care during illness.
- Medicine caution: valproate, high-dose or long-term propofol, some antibiotics (such as aminoglycosides in people with certain mtDNA variants) and statins can worsen mitochondrial function. Always tell doctors and anesthetists about your diagnosis.
- Treatments for specific types: a nucleoside therapy has been approved for TK2 deficiency in some countries, and research into gene and other therapies is active.
Outlook
The course ranges from mild, slowly progressive weakness compatible with a normal lifespan, typical of isolated myopathy and many CPEO cases, to severe multi-organ disease in childhood. Heart and breathing involvement are the main determinants of outlook. Regular specialist follow-up catches problems early.
Frequently asked questions
What are the first signs of mitochondrial myopathy?
Often unusual tiredness and muscle aching with ordinary exercise, followed by gradual weakness. In many adults, the first sign is slowly drooping eyelids and reduced eye movement. In children, poor growth, low muscle tone and developmental delay are common early signs.
Is mitochondrial myopathy inherited?
Yes. Changes in mitochondrial DNA are passed from the mother to all her children, though with varying severity. Changes in nuclear genes follow dominant or recessive inheritance. Some cases arise from new mutations. Genetic counseling helps families understand the risk.
Is mitochondrial myopathy fatal?
Not usually when it is limited to the muscles. Many people live a normal or near-normal lifespan with some disability. When the heart, brain or breathing muscles are significantly involved, the condition can shorten life, which is why heart and breathing are monitored regularly.
Can exercise help mitochondrial myopathy?
Yes. Regular, gradually increased aerobic and strength training improves endurance and strength and can increase the number of healthy mitochondria in muscle. Start under the guidance of a specialist or physical therapist and avoid sudden, exhausting exertion.
Sources
This guide was written from current patient and clinical guidance, including:
- National Institute of Neurological Disorders and Stroke (NINDS): Mitochondrial myopathies
- Muscular Dystrophy Association (MDA): Mitochondrial myopathies
- MedlinePlus Genetics: Mitochondrial DNA-related disorders
- United Mitochondrial Disease Foundation: Understanding mitochondrial disease
- Mitochondrial Medicine Society: Consensus statement on patient care